Has Todd Stewart, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $20,898 in general payments to Todd Stewart, DPM across 268 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Todd Stewart, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Todd Stewart, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Todd Stewart, DPM

Foot & Ankle Surgery · West Nyack, NYNPI 1306865860

Payments from drug & device makers

$20,898in general payments, 2019–2025

Across 268 payments — averaging $77.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Crossroads Extremity Systems, LLC$9K
Stryker$3K
Seapearl East, Inc$2K
Medical Device Business Services, Inc.$864
Amgen$731
International Life Sciences$666
plus $5K from 41 others

What the payments were for

Consulting fees$7,65037%
Travel & lodging$2,94514%
Food & beverage$8,21139%
Education$2,09210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Crossroads Extremity Systems, LLC	20	$8,516
Stryker(2 entities)	19	$2,504
Seapearl East, Inc	5	$2,267
Medical Device Business Services, Inc.	6	$864
Amgen(2 entities)	42	$731
International Life Sciences	2	$666
Organogenesis Inc.	18	$599
Extremity Medical	5	$450
Smith+Nephew	22	$399
Paragon 28, Inc.	6	$351
Paratek Pharmaceuticals, Inc.	28	$342
Johnson & Johnson(2 entities)	10	$342
Tenex Health Inc.	2	$305
Zimmer Biomet	4	$296
Treace Medical Concepts, Inc.	6	$230
Integra Lifesciences Corporation	7	$188
Next Science LLC	3	$170
AbbVie	8	$167
Kerecis Limited	1	$165
Bristol Myers Squibb	1	$124
Celularity Inc.	2	$116
Miromatrix Medical Inc.	1	$81
Heron Therapeutics, Inc.	4	$81
Bone Support Inc.	2	$78
Lifenet Health	3	$72
Curonix LLC	3	$69
Nevro Corp.	3	$67
Melinta Therapeutics, LLC	5	$67
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$55
Reprise Biomedical, Inc.	3	$52
Bioventus LLC	2	$50
Assertio Therapeutics, Inc.	2	$42
Fusion Orthopedics USA, LLC	1	$36
Averitas Pharma Inc.	2	$35
Hydrofera LLC	2	$34
Abbott	2	$31
Zyla Life Sciences, Inc.	2	$30
Nabriva Therapeutics, PLC	1	$28
Urgo Medical North America, LLC	1	$26
Orthofix Medical, Inc.	2	$25
AstraZeneca	1	$24
Medtronic	1	$24
Fidia Pharma USA Inc.	1	$24
Solventum Corporation	1	$20
Sebela Pharmaceuticals Inc.	1	$20
ANI Pharmaceuticals, Inc.	1	$20
Omeros Corporation	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,898 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York →

Medicare billing

Part B allowed, 2024

$293,549

Medicare patients

857

Services billed

3,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Colchicine	12	$1,118
Cefdinir	29	$491
CiclopiroxCiclopirox Olamine	20	$488
Mupirocin	58	$475
Fluocinonide	13	$349
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	17	$174
Doxycycline Hyclate	12	$148
Silver Sulfadiazine	12	$115
Gabapentin	13	$104
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	24	$88
Meloxicam	28	$67

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in West Nyack

Kenny LuongWest Nyack$58K
James McWilliamHarrison$4.7M
Jonathan DelandNew York$4.1M
George Vitole Roy$2.5M
Constantine DemetracopoulosNew York$888K
Anne JohnsonNew York$815K
Scott EllisNew York$644K
John KennedyNew York$613K
Michael KellerKingston$532K
Judith BaumhauerRochester$365K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →